2. Mion F, Marjoux S, Subtil F, et al. Botulinum toxin for the treatment of hypercontractile esophagus: results of a double-blind randomized sham-controlled study. Neurogastroenterol Motil. 2019;31(5):e13587.
3. Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol. 2011;9(10):824-833.
4. Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders. Gastroenterology. 2016;150(6):1368–1379.
5. Pandolfino JE, Roman S, Carlson D, et al. Distal esophageal spasm in high-resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology. 2011;141(2):469-475.
6. Almansa C, Heckman MG, DeVault KR, et al. Esophageal spasm: demographic, clinical, radiographic, and manometric features in 108 patients. Dis Esophagus. 2012;25(3):214-221.
7. Kraichely RE, Arora AS, Murray JA. Opiate-induced oesophageal dysmotility. Aliment Pharmacol Ther. 2010;31(5):601-606.
8. Eckardt VF, Köhne U, Junginger T, et al. Risk factors for diagnostic delay in achalasia. Dig Dis Sci. 1997;42(3):580-585.
9. Sadowski DC, Ackah F, Jiang B, et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010;22(9):e256–e261.
10. Zendehdel K, Nyrén O, Edberg A, et al. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol. 2011;106(1):57-61.
11. Zaninotto G, Costantini M, Rizzetto C, et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg. 2008;248(6):986-993.
12. Khatami SS, Khandwala F, Shay SS, et al. Does diffuse esophageal spasm progress to achalasia? Prospektywne badanie kohortowe. Dig Dis Sci. 2005;50(9):1605-1610.
13. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262–1279.
14. Bredenoord AJ. Hiperkurczowe zaburzenia motoryki przełyku czy czynnościowe objawy przełykowe i niezwiązana z nimi hiperkurczliwość? Neurogastroenterol Motil. 2019;31(5):e13594.
15. Roman S, Keefer L, Imam H, et al. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux. Neurogastroenterol Motil. 2015;27(11):1667–1674.
16. Ashraf HH, Palmer J, Dalton HR, et al. Czy pacjenci mogą określić poziom swojej dysfagii? World J Gastroenterol. 2017;23(6):1038–1043.
17. Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013;108(8):1238–1249.
18. Tutuian R, Mainie I, Agrawal A, et al. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance-manometry. Am J Gastroenterol. 2006;101(3):464–469.
19. McConaghy JR, Oza RS. Outpatient diagnosis of acute chest pain in adults. Am Fam Physician. 2013;87(3):177-182. Dostęp 9 kwietnia 2020 r. https://www.aafp.org/afp/2013/0201/p177.html
20. Spieker MR. Evaluating dysphagia. Am Fam Physician. 2000;61(12):3639–3648. Dostęp 9 kwietnia 2020 r. https://www.aafp.org/afp/2000/0615/p3639.html
21. Anderson WD III, Strayer SM, Mull SR. Common questions about the management of gastroesophageal reflux disease. Am Fam Physician. 2015;91(10):692-697. Dostęp 9 kwietnia 2020 r. https://www.aafp.org/afp/2015/0515/p692.html
22. Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Physician. 2011;83(5):547-552. Dostęp 9 kwietnia 2020 r. https://www.aafp.org/afp/2011/0301/p547.html
23. Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician. 2007;75(7):1027–1030. Dostęp 9 kwietnia 2020. https://www.aafp.org/afp/2007/0401/p1027.html
24. Weijenborg PW, Cremonini F, Smout AJ, et al. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil. 2012;24(8):747-757.
25. Ford AC, Forman D, Bailey AG, et al. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther. 2008;28(8):1013–1020.
26. Hughes J, Lockhart J, Joyce A. Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Clin Pharmacol. 2007;64(1):83-89.
27. Pimentel M, Bonorris GG, Chow EJ, et al. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol. 2001;33(1):27-31.
28. Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology. 2017;153(5):1205–1211.